Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staphylococcus Aureus Bacteraemia (Bacteremia/Bloodstream Infection); an International, Multicentre, Randomised Control Trial

NCT05361135 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05361135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staphylococcus Aureus Bacteraemia (Bacteremia/Bloodstream Infection); an International, Multicentre, Randomised Control Trial
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2023
Completion date
July 31, 2026
Enrollment
820 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection, sepsis, sepsis bacterial, staph sepsis, staphylococcus aureus bacteremia, staphylococcus aureus infection, staphylococcus aureus septicemia